Antithrombin Alfa Completed Phase 1 Trials for Altered Heparin Response / Cardiopulmonary Bypass Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01598883Understanding Heparin Resistance in Cardiac Surgery